Menu

Life Sciences

Transformational Health Home
Contact Us

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

Meet the Team

dorman_followwill.jpgDorman Followwill

Senior Partner

nitin_naik.jpgNitin Naik

Global Vice President

rhenu_bhuller.jpgRhenu Bhuller

Partner

UnmeshL.jpgUnmesh Lal

Program Manager


Expertise Areas

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in the following strategic and operational areas.

Pharmaceuticals & Biotech

Pharmaceuticals_Biotech.jpgCompetitive analysis series covering: oncology, diabetes/metabolic diseases, neurology, cardiovascular diseases and infectious diseases.

In Vitro Diagnostics & Research Tools

In_Vitro_Diagnostics_Research_Tools.jpgMarket analysis series covering: molecular Dx (incl. companion Dx), POCT, clinical lab services, next generation sequencing and chromatography/research antibodies.

Emerging Technologies

Emerging_Technologies.jpgMarket insights series covering: regenerative medicine, biosimilars, generics 2.0, CRAMS, digital pathology, downstream bioprocessing and antibody drug conjugates.

TH_LS.pngOur Transformational Health Content Covers These Critical Issues:

  • Innovating business models that promise sustainable revenue streams
  • Designing integrated data platforms that empower consumers
  • Developing strategic partnerships that bring novel products and services to the market
  • Establishing industry best practices
  • Identifying emerging markets opportunities
Recent Advances in Life Science Technologies

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across different technologies, including genetic testing for cancer, exosome technology capabilities, and gene delivery approaches.

The Genetic Technology TechVision Opportunity Engine (TOE)…

Growth Opportunities in the US In Vitro Diagnostics (IVD) Market, Forecast to 2021

The In Vitro Diagnostics (IVD) landscape in the United States is extremely dynamic, with a high level of merger and acquisition activity with many high-value deals still pending. Both clinical laboratories and manufacturers are increasingly vying for smaller specialized niche technology companies to…

Recent Advances in Cancer Immunotherapy and Tumor Profiling Technologies

Cancer immunotherapy and cancer profiling are key areas of growth across the healthcare community. These vital areas will define the future of how cancer is screened, diagnosed, managed, and monitored. With technology areas such as exosome technology being implemented in profiling tumors, a paradigm…

Bioinformatics and Advanced Analytics Powering Drug Discovery

Personalized medicine has brought forth a new avenue for innovation. Currently, genomics is being accelerated into extensive use across drug development and drug discovery. The capability of genomics has brought about the resurgence of biomarkers that could effective patient stratification, ensuring…

Advancements across Health and Wellness

Innovations across health and wellness are improving the quality of diagnosis and prevention. Currently, preventative solutions are gaining a wider acceptance, while solutions like probiotics that supplement the nutrition needs of an individual are important for ensuring a healthy population.…

Therapeutic Breakthroughs in Multiple Sclerosis

This edition of the Future Tech TOE primarily encompasses comprehensive analyses of key emerging therapies across multiple sclerosis (MS). The service also includes treatment overviews, clinical pipeline analysis, IP and funding analysis, and emerging innovations across MS therapies. Furthermore,…

Respondents Show Significant Interest in Developing Clinical NGS-based Tests for Infectious Disease Testing Applications

Next-generation sequencing and the use of genomics in diagnosis and treatment have generated many headlines in recent years, both for advancements on the research front, as well as in the development of diagnostics and pharmaceutical products that leverage genomics in oncology and other…

Diagnostic and Therapeutic Developments across Global Healthcare

This Genetic Technology TOE depicts recent diagnostic and therapeutic advances across the global healthcare industry. Clinical trial scenario for monoclonal antibody therapies for migraine are also depicted.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D…

Top 9 Predictions for Global Healthcare 2017

Public and political pressure on controlling surging drug prices globally will compel health authorities to take transparency measures around drugs pricing, especially for some of the expensive diabetes and cholesterol medicines

Top Technologies in Sensors and Instrumentation, 2017

The technology and innovation research service covers the top 10 sensor and instrumentation technologies that will have highest impact in the near- to medium-term

Key technologies in the sensor and instrumentation cluster were evaluated to arrive at the top 10 technologies for 2017.

The…

Frost & Sullivan's Growth Consulting services support our clients who require customized and collaborative solutions to help their companies meet revenue targets, capture market share and expand portfolios. Most projects are focused on addressing highly strategic challenges that require creative research techniques and deep market insights to address our clients’ specific needs. Our projects focus on ten primary areas:

  • Mergers & Acquisitions Due Diligence
  • Geographic Expansion
  • New Product Development and Concept Testing
  • New Product Launch
  • Competitive Strategy
  • Distribution Channel Optimization
  • Vertical Market Expansion
  • Customer Strategy
  • Pricing Strategies
  • Technology Strategy (Licensing, Applications)
  • Strategic Partnerships
  • Digital Transformation and Strategies

Growth Consulting clients are primarily healthcare technology and service providers such as medical device and diagnostic companies, pharmaceutical and biotech manufacturers, and firms in the healthcare information technology and connected health markets. Companies supporting these firms, whether for professional services and logistics or components and software, also regularly turn to us for insight into the multi-billion dollar healthcare vertical. Our broad base of capabilities can be leveraged by any entity seeking to grow in the intersection between healthcare and technology innovation.

Recognizing each project as unique, Frost & Sullivan crafts the optimal approach to addressing our clients’ needs. These tools may include:

  Qualitative Quantitative
Existing Knowledge
  • Existing analyst knowledge
  • Published Frost & Sullivan research deliverables
  • Frost & Sullivan events
  • Industry contacts and relationships
  • Secondary research 
  • Third-party databases
  • Mining internal Frost & Sullivan databases
  • External publically-available data sources
  • Contracted data sources for resale or integration
  • Creative modeling and forecasting
New Knowledge
  • One-on-one interviews
  • Focus groups
  • Panels/forums/workshops
  • Observational research/audits
  • Conference attendance/ research
  • Competitive intelligence
  • Ideation/brainstorming
  • Perceptual mapping studies
  • Delphi studies
  • Surveys (CATI, online, tradeshow)
  • Utility trials/studies
  • Epidemiology surveys
  • Conjoint analysis
  • Value/ROI modeling
  • Other economic studies/modeling

 

Why Partner with Frost & Sullivan?

  • Deep subject matter expertise with highly educated consultants focusing entirely on the healthcare technology sector
  • More than 45 locations around the world to provide unparalleled global access and insights
  • Collaborative teams that formed across industry sectors supporting healthcare technology vertical, e.g. materials, mobility and wireless, power systems, sensors, software, logistics, transportation, food, and others
  • Strong reputation and deep network of healthcare technology contacts to support rapid and insightful industry research and networking
  • Decades of experience in epidemiological, financial, and competitive forecast modelling, providing quantitative rigor and to all our engagements
  • Proven processes and methodologies tested across hundreds of projects with the world’s leading firms
  • Creative thought leadership and deep insights into market dynamics to help product development teams and executives create and validate new whitespace opportunities
  • Ability to design and facilitate on-site workshops with our clients which use proprietary exercises to evaluate opportunities, develop strategies and reach consensus on next steps
  • An established brand known for excellence in the field of healthcare technology innovation that can be leveraged for custom whitepapers, e-broadcasts and other tactical marketing initiatives
  • A highly-skilled team of quantitative research professionals capable of designing and executing complex methodologies, including conjoint analysis, MaxDiff, multivariate analysis and others
  • Access to a broad network of affiliated service partners and third party data tools to extend our capabilities
Types of Companies Examples of Recent Projects
Healthcare Providers Assessing Licensing Potential for an Enterprise Learning System of a Leading Tertiary Healthcare Provider
Suppliers/ Service Providers to Industry Interactive Digital Whitepaper with Embedded Video on the Future of the Global Healthcare Products Supply Chain for a Major Logistics Company
Consumer Health Competitive Profiles on 1,200+ Weight Loss and Skin Care Product Available Worldwide to Support R&D Efforts of a Major Competitor
Investors Buy-Side Valuation Analysis and Financial Modeling for Investment Consideration in an Energy-Based Medical Device  Start Up
Professional Associations Annual Customer Survey on U.S. Purchasing Patterns for Laboratory Products Commissioned by a Leading Industry Association 

 

globe_abstract-network.pngFrost & Sullivan’s Growth Workshops help clients establish a narrow portfolio of key market opportunities from a larger pool of options.  These interactive sessions help clients identify the strongest opportunities in the market and brainstorm strategies for pursuing those opportunities. Growth Workshops run the gamut of market analysis, from opportunity identification to strategy development to planning and implementation. Each workshop’s design is based on the full breadth of client objectives and desired outcomes.

Growth Workshop Consultants help clients funnel and prioritize which opportunities fit best with the company's internal capabilities. During these workshops, attendees gain market knowledge and are trained on evaluation tools and techniques to translate market, competitive, technical, regulatory and economic implications into specific growth opportunities.

Frost & Sullivan’s Growth Workshops use a range of tools and exercises to help clients identify and prioritize key market opportunities, such as:

  • Opportunity/Fit Matrix
  • Decision Support Scorecard
  • Strategy Mapping
  • Executive Alignment Surveys

"Frost & Sullivan worked with Tissue and Eye Services (a division of NHS Blood and Transplant) to deliver an informed opinion on market potential and dynamics in the tissues market. Their thought leadership on market segmentation, market share and insights into what influenced customers buying behaviour enabled us to reassess our strategy and focus on products that would deliver growth. Their partnership approach worked for us and they were responsive to our challenge and questions in specific areas of interest."

NHS

"We have been very satisfied with the consulting project we commissioned with Frost & Sullivan. The analysts were responsive to our needs and accessible during the project. The finished research was quite thorough and, as we later saw, proved to be a highly accurate depiction of the market."

Abbott Laboratories

"We have found Frost & Sullivan’s work to be nothing short of excellent. The consulting project results were concise and cohesive, leading us to better understand a market that is usually complex and difficult to research."

Novo Nordisk

"We have relied on Frost & Sullivan’s strategic research studies for reliable insights into several competitive markets. Their ability to identify and analyze industry-specific trends gives their clients not only a clear indication of where markets are going, but why they are going there."

Gen-Probe

"The team was knowledgeable and not only determined what information would be helpful in the long-term, but delivered it in a short amount of time. The study helped us make good strategic decisions, backed by reliable market-based information."

VISX

“It was great to talk to your analysts and grateful for everything you and the team do to support our company on a daily basis.”

Global Market Intelligence Manager, Medical Devices Company

"You are my most trusted source for information on a myriad of topics.”

Fortune 500 Company

"This looks very comprehensive and a huge piece of work. Definitively a vendor we can consider for some of our later stage assets."

Global Strategic Marketing, Oncology, Pharma Company